ConSynance Therapeutics Reports Positive Phase 1 Results for

ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients

ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Tennessee , United States , New York , Rensselaer , , Consynance Therapeutics Inc , Founder Consynance Therapeutics Inc , Vanderbilt Medical Center , Sarah Sheldrick Consynance Therapeutics Inc , Wall Street , Synance Therapeutics , Prader Willi Syndrome , Triple Monoamine Reuptake Inhibitor , Ascending Dose , Multiple Ascending Dose , Shuang Liu , Consynance Therapeutics , New Chemical Entity , New York Based , Harmony Biosciences , Looking Statements , Founder Consynance Therapeutics , Sarah Sheldrick Consynance Therapeutics ,